Omnicell, Inc. (OMCL) Stock
OMCL Key Statistics
About Omnicell, Inc.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
CEO: Randall A. Lipps. Company website
OMCL — Frequently Asked Questions
What is the OMCL stock price today?
Omnicell, Inc. (OMCL) trades at $35.57, down 0.92% on the day, as of Nov 12, 2026 09:20 UTC.
What is Omnicell, Inc.'s market cap?
Omnicell, Inc. has a market capitalisation of $1.62B, calculated from the live OMCL share price and shares outstanding.
What is the P/E ratio of OMCL?
OMCL trades at a trailing P/E of 36.82, from earnings per share of $0.97 over the last twelve months.
How much revenue does Omnicell, Inc. make?
Omnicell, Inc. generated revenue of $1.24B over the trailing twelve months, which puts the stock at 1.30 times sales.
What is the 52-week range for OMCL?
OMCL has traded between $31.75 and $55.00 over the past 52 weeks, and the last price is 35.3% below that high.
Is Omnicell, Inc. profitable?
Yes. Omnicell, Inc. keeps 3.59% of revenue as net income over the trailing twelve months.
What is the analyst price target for OMCL?
Wall Street analysts rate OMCL Buy, with an average price target of $57.50, 61.7% above the current price.
What sector is Omnicell, Inc. in?
Omnicell, Inc. is classified under the Healthcare sector and the Medical - Healthcare Information Services industry, and is domiciled in US.
Who is the CEO of Omnicell, Inc.?
Randall A. Lipps is the chief executive of Omnicell, Inc., which employs 3,450 people.
Where can I track OMCL in real time?
QFI Terminal shows OMCL with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See OMCL live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open OMCL in Terminal See plans